Home

hiány snazzy Üzemzavar tia aspirin Halász elmélet Medve

Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar - ScienceDirect
Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar - ScienceDirect

THALES Secondary Efficacy | BRILINTA® (ticagrelor) tablets | For HCPs
THALES Secondary Efficacy | BRILINTA® (ticagrelor) tablets | For HCPs

Antithrombotic therapies (Chapter 18) - The Stroke Book
Antithrombotic therapies (Chapter 18) - The Stroke Book

Medical therapies (Chapter 24) - Transient Ischemic Attack and Stroke
Medical therapies (Chapter 24) - Transient Ischemic Attack and Stroke

NEJM on Twitter: "#VisualAbstract: In patients with minor ischemic stroke or TIA, aspirin + clopidogrel reduces risk of major ischemic events but increases risk of major hemorrhage at 90 days than aspirin
NEJM on Twitter: "#VisualAbstract: In patients with minor ischemic stroke or TIA, aspirin + clopidogrel reduces risk of major ischemic events but increases risk of major hemorrhage at 90 days than aspirin

290 Stroke and TIA Triple Distilled - The Curbsiders
290 Stroke and TIA Triple Distilled - The Curbsiders

EMNote.org - EMNote
EMNote.org - EMNote

Ticagrelor, aspirin benefits in TIA outweigh risk over 30-day treatment period: Neurology
Ticagrelor, aspirin benefits in TIA outweigh risk over 30-day treatment period: Neurology

Dual antiplatelet Tx for stroke prevention: Worth the risk? | MDedge Family Medicine
Dual antiplatelet Tx for stroke prevention: Worth the risk? | MDedge Family Medicine

Cinnamon and Aspirin for Mild Ischemic Stroke or Transient Ischemic Attack: A Pilot Trial - ScienceDirect
Cinnamon and Aspirin for Mild Ischemic Stroke or Transient Ischemic Attack: A Pilot Trial - ScienceDirect

Contraindications to aspirin in suspected TIA | Download Table
Contraindications to aspirin in suspected TIA | Download Table

Dual Antiplatelet Therapy Lowers Stroke, Death Rates in Ischemic Stroke/TIA Patients Better than Aspirin Alone - Physician's Weekly
Dual Antiplatelet Therapy Lowers Stroke, Death Rates in Ischemic Stroke/TIA Patients Better than Aspirin Alone - Physician's Weekly

Clopidogrel and Aspirin in Acute Ischemic Stroke and High‐Risk TIA | Semantic Scholar
Clopidogrel and Aspirin in Acute Ischemic Stroke and High‐Risk TIA | Semantic Scholar

Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke | Stroke
Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke | Stroke

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin | Stroke
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin | Stroke

Stroke Guidelines | The International Aspirin Foundation
Stroke Guidelines | The International Aspirin Foundation

Stroke Guidelines | The International Aspirin Foundation
Stroke Guidelines | The International Aspirin Foundation

Current Recommendations for Secondary Stroke Prevention
Current Recommendations for Secondary Stroke Prevention

Immediate aspirin after mini-stroke substantially reduces risk of major stroke | University of Oxford
Immediate aspirin after mini-stroke substantially reduces risk of major stroke | University of Oxford

THALES: Ticagrelor plus aspirin reduces 30-day recurrent stroke, death vs. aspirin alone
THALES: Ticagrelor plus aspirin reduces 30-day recurrent stroke, death vs. aspirin alone

Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke

VisualAbstract: Ticagrelor and aspirin vs. aspirin alone for ischemic stroke or TIA | 2 Minute Medicine
VisualAbstract: Ticagrelor and aspirin vs. aspirin alone for ischemic stroke or TIA | 2 Minute Medicine

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack | Stroke
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack | Stroke

Contraindications to aspirin in suspected TIA | Download Table
Contraindications to aspirin in suspected TIA | Download Table

Dual antiplatelet therapy with ticagrelor may increase the risk of all bleeding events in patients with minor strokes or high risk TIAs: a meta-analysis | Stroke and Vascular Neurology
Dual antiplatelet therapy with ticagrelor may increase the risk of all bleeding events in patients with minor strokes or high risk TIAs: a meta-analysis | Stroke and Vascular Neurology